Protagen Raises $12.7M to Support Protein Array Diagnostic Development

The company said it will use the proceeds to expand its diagnostics business unit and to develop serum-based assays for the early detection of multiple sclerosis and prostate cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.